Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

CRISPR & Cas Genes Market Growing funding in gene therapy worldwide is a prominent factor driving the CRISPR & Cas genes market.

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Scientists have linked roughly five percent of adult cancers to mutations in genes called FOCAD and TTC37. Another gene known ...

Argentina's award-winning mare Polo Pureza will have her genes, or at least most of them, live on in five genetically edited horses designed to outrun the polo legend herself. Scientists at Argentine ...